Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bausch Health Companies Inc. Common Stock (NY: BHC ) 7.610 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EST, Dec 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1 Open 7.610 Bid (Size) 3.070 (1) Ask (Size) 8.030 (2) Prev. Close 7.610 Today's Range 7.610 - 7.610 52wk Range 3.960 - 11.46 Shares Outstanding 358,808,755 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb December 12, 2024 Via ACCESSWIRE Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt December 07, 2024 Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value. Via Benzinga Topics Supply Chain Exposures Supply Chain Performance YTD -2.19% -2.19% 1 Month -3.55% -3.55% 3 Month -6.17% -6.17% 6 Month +10.45% +10.45% 1 Year -1.81% -1.81% More News Read More Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day December 05, 2024 Via ACCESSWIRE Bausch Health Appoints New Chief Medical Officer and Head of R&D December 02, 2024 Via ACCESSWIRE Bausch Health Announces Third Quarter 2024 Results October 30, 2024 Via ACCESSWIRE Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners August 13, 2024 Via ACCESSWIRE Bausch Health Announces Second Quarter 2024 Results July 30, 2024 Via ACCESSWIRE Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis November 18, 2024 Via ACCESSWIRE PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS November 18, 2024 Via ACCESSWIRE Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday November 01, 2024 Via Benzinga ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence October 27, 2024 Via ACCESSWIRE Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt October 26, 2024 Via Benzinga Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings July 29, 2024 Via Benzinga Topics Economy Exposures Interest Rates Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags October 21, 2024 Via Benzinga Topics Bankruptcy Stocks Exposures Financial Legal US Equities Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces October 14, 2024 Via Benzinga Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024 October 09, 2024 Via ACCESSWIRE Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises October 08, 2024 Via ACCESSWIRE Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value September 25, 2024 Via MarketBeat Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? September 22, 2024 Via Benzinga Topics Economy Exposures Interest Rates Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues September 16, 2024 Via Benzinga Topics Supply Chain Exposures Supply Chain Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? September 16, 2024 Via Investor's Business Daily Bank Of Canada Cuts Rates Again As Inflation, Labor Market Cool: Canadian Stocks Rebound, Loonie Strengthens September 04, 2024 Via Benzinga Topics Economy Exposures Interest Rates Bausch Health Solvency Remains A Concerns, Analyst Downgrades Stock August 02, 2024 Via Benzinga US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday? August 01, 2024 Via Benzinga Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November August 01, 2024 Via Benzinga Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
